pantoprazole has been researched along with Hypoparathyroidism in 3 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
Hypoparathyroidism: A condition caused by a deficiency of PARATHYROID HORMONE (or PTH). It is characterized by HYPOCALCEMIA and hyperphosphatemia. Hypocalcemia leads to TETANY. The acquired form is due to removal or injuries to the PARATHYROID GLANDS. The congenital form is due to mutations of genes, such as TBX1; (see DIGEORGE SYNDROME); CASR encoding CALCIUM-SENSING RECEPTOR; or PTH encoding parathyroid hormone.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fatuzzo, P | 1 |
Portale, G | 1 |
Scollo, V | 1 |
Zanoli, L | 1 |
Granata, A | 1 |
Basterra-Gortari, FJ | 1 |
Goñi Iriarte, MJ | 1 |
Toni García, M | 1 |
Iriarte Beroiz, A | 1 |
Famularo, G | 1 |
Minisola, G | 1 |
Bravi, MC | 1 |
Colucci, P | 1 |
Gasbarrone, L | 1 |
3 other studies available for pantoprazole and Hypoparathyroidism
Article | Year |
---|---|
Proton pump inhibitors and symptomatic hypomagnesemic hypoparathyroidism.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Biomarkers; Cerebellar Diseases; Dietary Supplements; | 2017 |
[Asymptomatic hypomagnesemic hypoparathyroidism induced by pantoprazol].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Humans; Hypoparathyroidism; Magnesium; Male; Pantopra | 2011 |
Tetany, hypomagnesemia, and proton-pump inhibitors.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Biomarkers; Female; Humans; Hypoparathyroidism; Magnesium; | 2012 |